Aprea Therapeutics, Inc.
APRE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001781983
No open-market purchases or sales by Aprea Therapeutics, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $1.90M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Aprea Therapeutics, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Of which not filed for Q1 2022 | Q1 2022 | Change |
|---|---|---|---|---|
| Holders | 41 | 1 | 40 | 0 |
| Shares | 3.61M | 103 | 2.42M | −1.19M (−33.0%) |
| Value | $10.4M | $0 | $4.50M | −$5.86M (−56.6%) |
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (9)
Institutions that held Aprea Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Crestline Management, LP | 49,451 | $92.0K | 0.01% |
| Cubist Systematic Strategies, LLC | 20,572 | $38.0K | 0.00% |
| Gyon Technologies Capital Management, LP | 20,570 | $38.0K | 0.03% |
| Two Sigma Investments, LP | 18,610 | $35.0K | 0.00% |
| D. E. Shaw & Co., Inc. | 16,884 | $31.0K | 0.00% |
| Stifel Financial Corp | 10,000 | $19.0K | 0.00% |
| Simplex Trading, LLC | 1,773 | $3.00K | 0.00% |
| Citigroup Inc | 500 | $1.00K | 0.00% |
| Quent Capital, LLC | 75 | $0 | 0.00% |
Sold out (9)
Institutions that held Aprea Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Pura Vida Investments, LLC | 433,859 | $1.25M |
| XTX Topco Ltd | 27,285 | $78.0K |
| Jane Street Group, LLC | 21,202 | $61.0K |
| ExodusPoint Capital Management, LP | 17,326 | $50.0K |
| Dynamic Technology Lab Private Ltd | 15,173 | $44.0K |
| Squarepoint Ops LLC | 14,880 | $43.0K |
| Engineers Gate Manager LP | 13,395 | $38.0K |
| FMR LLC | 200 | $1.00K |
| Macquarie Group Ltd | 183 | $1.00K |
Not filed for Q1 2022 yet (1)
Institutions that held Aprea Therapeutics, Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| NEXT Financial Group, Inc | 103 | $0 |